Author name: Leonardo Arias

Durante siglos, el despertar de un volcán fue un evento envuelto en el misterio y el terror. Sin embargo, en 2026, la ciencia ha logrado algo que parecía imposible: transformar el caos geológico en datos predecibles. Gracias a una combinación de inteligencia artificial, s …

En la era de las dietas y el marketing de los suplementos, la pregunta parece sencilla pero esconde una complejidad biológica fascinante: ¿Existe realmente un alimento que destaque por encima de todos los demás en densidad nutricional?   Como es habitual, solemos desconfi …

The FDA is signaling change, but actual success depends on more than simply bringing in a new leader at the Center for Biologics Evaluation and Research; it requires accountability, transparency and consistent action.

The company plans to introduce AI agents for personas such as sales reps, leadership and marketing teams.

Approved Thursday via the FDA’s Commissioner’s National Priority Voucher program, Otarmeni is the first gene therapy for hearing loss—and the first treatment to target an underlying cause of the condition.

The takeover will give Amneal control of four facilities to manufacture biosimilars for a planned wave of launches in the coming years.

Though chatbots could have some benefits for mental health access, the physician lobby argued “immediate attention is required” to avoid harming patients looking for support.

Executives said consumer fears and aggressive denials from payers fueled declining volumes in the quarter, leading CHS to a $58 million loss. Still, the hospital operator expects volumes to pick up in the back half of the year.

The pathway is designed to reduce the delay between FDA authorization and Medicare coverage for certain Class II and Class III breakthrough medical devices.

The pathway is designed to reduce the delay between FDA authorization and Medicare coverage for certain Class II and Class III breakthrough medical devices.